Stryker Net Acquisitions/Divestitures 2010-2024 | SYK
Stryker annual/quarterly net acquisitions/divestitures history and growth rate from 2010 to 2024. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
- Stryker net acquisitions/divestitures for the quarter ending December 31, 2024 were $-1.628B, a 317.44% increase year-over-year.
- Stryker net acquisitions/divestitures for the twelve months ending December 31, 2024 were $-3.806B, a 225.3% increase year-over-year.
- Stryker annual net acquisitions/divestitures for 2024 were $-1.628B, a 317.44% increase from 2023.
- Stryker annual net acquisitions/divestitures for 2023 were $-0.39B, a 84.78% decline from 2022.
- Stryker annual net acquisitions/divestitures for 2022 were $-2.563B, a 656.05% increase from 2021.
| Stryker Annual Net Acquisitions/Divestitures (Millions of US $) |
|
|---|---|
| 2024 | $-1,628 |
| 2023 | $-390 |
| 2022 | $-2,563 |
| 2021 | $-339 |
| 2020 | $-4,222 |
| 2019 | $-802 |
| 2018 | $-2,451 |
| 2017 | $-831 |
| 2016 | $-4,332 |
| 2015 | $-153 |
| 2014 | $-916 |
| 2013 | $-2,320 |
| 2012 | $-154 |
| 2011 | $-2,066 |
| 2010 | $-265 |
| 2009 | $-570 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $142.748B | $22.595B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||